Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial
Authors
- C D Xia (ORCID: https://orcid.org/0000-0003-0418-0371)
- Rebecca A. Hubbard (ORCID: https://orcid.org/0000-0003-0879-0994)
- David M. Mintzer
- Marina Messinger
- Nicholas S. Wilcox (ORCID: https://orcid.org/0000-0002-3693-7650)
- Saro H. Armenian (ORCID: https://orcid.org/0000-0003-2604-8603)
- Amanda M. Smith (ORCID: https://orcid.org/0000-0002-9881-236X)
- Amy S. Clark (ORCID: https://orcid.org/0000-0002-3685-6535)
- Vivek Narayan (ORCID: https://orcid.org/0000-0002-8205-738X)
- Anran Huang (ORCID: https://orcid.org/0000-0003-1435-1576)
- Hayley Knollman
- Jessica Wang (ORCID: https://orcid.org/0000-0001-7348-0509)
- Jenica Upshaw (ORCID: https://orcid.org/0000-0001-5801-5481)
- Bonnie Ky (ORCID: https://orcid.org/0000-0002-6628-9981)
- Wonyoung Jung (ORCID: https://orcid.org/0000-0003-4749-4637)
- Peter P. Liu (ORCID: https://orcid.org/0000-0002-3017-1199)
- Daniel Koropeckyj-Cox (ORCID: https://orcid.org/0009-0009-6446-3868)
- Zhen Chen
- Liyong Zhang
- Payal Shah (ORCID: https://orcid.org/0009-0004-7225-1674)
- Kyunga Ko (ORCID: https://orcid.org/0000-0001-8582-2633)
- Saveri Bhattacharya
- Jordan Isaacs
Institutions
- Tufts Medical Center (US)
- University of Ottawa (CA)
- Brown University (US)
- City of Hope (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1007/s10549-025-07636-3
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- American Heart Association
- Genome Canada
- National Institutes of Health